Reversal of experimental pulmonary hypertension by PDGF inhibition
Ralph T. Schermuly(Justus-Liebig-Universität Gießen)
Cited by 1,055
Related Papers
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|784
p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy
|American Journal of Respiratory Cell and Molecular Biology|2017|119
The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats
|PLoS ONE|2012|113
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
|Nature Communications|2019|96
Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018
|International Journal of Cardiology|2018|39